Clinical Trials

Shuttle Pharmaceuticals Holdings, Inc., a discovery and development stage specialty pharmaceutical company focused on improving the outcomes of cancer patients treated with radiation therapy (RT), today announced it has signed an agreement with the University of Iowa (UI) Pharmaceuticals...

LEO Pharma, a global leader in medical dermatology, and ICON plc announced a strategic partnership that will enable LEO Pharma to scale clinical trial execution that is patient-centric and cost effective, and which will support the company’s overall ambition...

A new approach that has been created at the Medical University of South Carolina that specifically aims at enhancing clinical trial eligibility has shown positive results. The patient outreach recruitment team that has been floated by the South Carolina Clinical...

A new weapon in the arsenal of cancer cells' treatment resistance, according to a study conducted by the Garvan Institute of Medical Research, is their ability to respond randomly to chemotherapy. Understanding why some tumour cells develop resistance to chemotherapy...

ID93+GLA-SE, a freeze-dried tuberculosis vaccine, was confirmed to be safe in the first clinical study of any subunit TB vaccine in a temperature-stable form. The effectiveness of a regimen in which non-thermostable ID93 and liquid GLA-SE are held in two...

Viz.ai has announced it will use its Viz Recruit platform to optimise patient enrolment for the National Institutes of Health (NIH)-funded Pulmonary embolism—thrombus removal with catheter-directed thrombolysis (PE-TRACT) clinical trial. The company claims that PE-TRACT will be the most rigorous...

Greenphire, the global leader in financial lifecycle management for clinical trials, announced significant expansion and growth of ConneX, the industry's most comprehensive clinical trial travel solution designed to help meet the retention goals of global studies. ConneX has expanded upon...